90 related articles for article (PubMed ID: 6328796)
1. Toxoplasmacidal activity of Obioactin derived from hydrolyzed Toxoplasma immune bovine serum in heterologous cell cultures.
Suzuki N; Izumo A; Sakurai H; Saito A; Miura H; Osaki H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):356-66. PubMed ID: 6328796
[TBL] [Abstract][Full Text] [Related]
2. Correlation between release of reactive oxygen intermediates and inhibition of Toxoplasma multiplication in mouse peritoneal and alveolar macrophages and kidney cells after in vitro incubation with Obioactin, lonomycin A, muramyl dipeptide, lipopolysaccharide or Toxoplasma lysate antigen.
Saito A; Sakurai H; Saito T; Taji S; Miyagami T; Suzuki N; Seitz HM; Osaki H
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):446-54. PubMed ID: 3660981
[TBL] [Abstract][Full Text] [Related]
3. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
[TBL] [Abstract][Full Text] [Related]
4. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of Obioactin.
Osaki H; Furuya M; Nagasawa H; Suzuki N
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):328-34. PubMed ID: 6328795
[TBL] [Abstract][Full Text] [Related]
6. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its effect on toxoplasma multiplication in the mouse kidney cells.
Matsumoto Y; Nagasawa H; Sakurai H; Sasaki S; Suzuki N
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):383-91. PubMed ID: 7029969
[TBL] [Abstract][Full Text] [Related]
7. Effects of neonatal spleen cell products on the multiplication of toxoplasma in rat peritoneal macrophages.
Sakurai H; Igarashi I; Omata Y; Saito A; Suzuki N
J Immunol; 1983 Sep; 131(3):1527-30. PubMed ID: 6886423
[TBL] [Abstract][Full Text] [Related]
8. Effect of obiopeptide and obioactin on the toxoplasmacidal activity, glucose consumption and ruffle formation in mouse macrophages.
Fujii Y; Maki Y; Claveria FG; Igarashi I; Saito A; Ono K; Suzuki N
J Vet Med Sci; 1992 Apr; 54(2):351-3. PubMed ID: 1318754
[No Abstract] [Full Text] [Related]
9. Effects of reactive oxygen intermediate scavengers on the antitoxoplasmic activity of activated macrophages.
Saito A; Igarashi I; Miyahara K; Venturini C; Claveria FG; Hirose T; Suzuki N; Ono K
Parasitol Res; 1992; 78(1):28-31. PubMed ID: 1584743
[TBL] [Abstract][Full Text] [Related]
10. Microbicidal activity of toxoplasma immune beagle plasma and lymphokines to toxoplasma multiplication in host cells.
Takei Y; Miyagami T; Nagasawa H; Sasaki H; Kawakami T; Omata Y; Suzuki N
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):392-402. PubMed ID: 6171122
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of obiopeptide-1, a synthetic peptide derived from the native immune-regulator obioactin.
Suzuki N; Sakurai H; Saito A; Igarashi I; Omata Y; Osaki H
Nihon Juigaku Zasshi; 1990 Oct; 52(5):907-14. PubMed ID: 2280500
[TBL] [Abstract][Full Text] [Related]
12. Unique differences in infectivity and seroreactivity of Toxoplasma harvested from mice infected for different lengths of time.
McCabe RE; Catterall JR; Remington JS
J Parasitol; 1987 Dec; 73(6):1152-7. PubMed ID: 3437353
[TBL] [Abstract][Full Text] [Related]
13. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
[TBL] [Abstract][Full Text] [Related]
14. Modulator effect of Toxoplasma lysate antigen in mice experimentally infected with Plasmodium berghei.
Suzuki N; Kikushima K; Miyagami T; Igarashi I; Sakurai H; Saito A; Osaki H
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):422-34. PubMed ID: 3310463
[TBL] [Abstract][Full Text] [Related]
15. [Effect of IL-6 on the multiplication of Toxoplasma gondii].
Fang Y; Tan Y; Zhang Y; Li J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):106-8. PubMed ID: 12563793
[TBL] [Abstract][Full Text] [Related]
16. Suppression of macrophage antimicrobial activity by a tumor cell product.
Szuro-Sudol A; Murray HW; Nathan CF
J Immunol; 1983 Jul; 131(1):384-7. PubMed ID: 6408180
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa.
Murray HW
J Reticuloendothel Soc; 1982 Jun; 31(6):479-87. PubMed ID: 6288939
[TBL] [Abstract][Full Text] [Related]
18. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
Murray HW; Cohn ZA
J Exp Med; 1980 Dec; 152(6):1596-609. PubMed ID: 6256463
[TBL] [Abstract][Full Text] [Related]
19. Parasiticidal activity of bovine lactoperoxidase against Toxoplasma gondii.
Tanaka T; Murakami S; Kumura H; Igarashi I; Shimazaki K
Biochem Cell Biol; 2006 Oct; 84(5):774-9. PubMed ID: 17167541
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii.
Nguyen BT; Stadtsbaeder S
Pathol Eur; 1975; 10(4):307-15. PubMed ID: 1208122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
